• 54,843+ CME Conference Registrations Sold
  • 164,528+ Medical Conferences
  • 297 Specialties
  • 11,711 Organizers
  • 159,489 Speakers
  • 159 Countries
  • 4,847 Cities
Home  >  Conferences  >  New Horizons in Nephrology: Glomerular Disease in 2020 - Moving the Needle
CME : 7.25

New Horizons in Nephrology: Glomerular Disease in 2020 - Moving the Needle

Oct 16, 2020 12:00 AM-12:00 AM   |   Philadelphia, Pennsylvania  United States of America
Organized by : Penn Medicine - Continuing Medical and Interprofessional Education
Specialties : Nephrology
Conference Brochure

New Horizons in Nephrology: Glomerular Disease in 2020 - Moving the Needle is organized by Penn Medicine - Continuing Medical and Interprofessional Education and will be held on Oct 16, 2020, at Gift of Life Donor Program, Philadelphia, Pennsylvania, United States of America.

Target Audience:

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit
Penn Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Overview:
Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which are associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases, and the current guidelines for managing glomerular disease require updating. Therefore it is important for physicians to stay current with these new approaches to managing glomerular diseases.

• Update how recent and ongoing clinical trials may impact the treatment of IgA nephropathy
• Review recent data on the treatment of lupus nephritis
• Explain how recent randomized controlled trials in ANCA associated vasculitis are informing clinical   management of this disease
• Gain expertise in diagnosing and treating membranous nephropathy in 2020
• Develop comfort and competency in the use of serum anti PLA2R antibody testing in patients with   membranous nephropathy
• Review how recent genetic studies may impact the diagnosis and treatment of patients with glomerular   disease


Vivian Tucker
Vivian Tucker


Help Desk

1(800) 828-2059


Conference Fee Details

Conference Fee : USD $75.00
Early Fee : NA
Early Fee Last date : NA

  • Drive Walk Transit Bicycle

Venue Address

Gift of Life Donor Program
401 N 3rd St
Philadelphia, Pennsylvania, United States of America

Plan Your Travel

Hotel Dealing
Traveller insurance
Traveller insurance

Please Rate this Conference


Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

40 miles from venue
Price : USD 168.32 Per Night

Session Details

Session Topic Start Time End Time Location Speakers

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter


Subscribe to our newsletter and receive updates on medical conferences, board review courses and news